20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T8469 | LQZ-7I | Survivin | |
LQZ-7I is an inhibitor of surviving-targeting. It orally effectively inhibits xenograft tumor growth and induces survivin loss in tumors | |||
T5697 | BMS-1166 | PD-1/PD-L1 | |
BMS-1166 is a potent PD-1/PD-L1 interaction inhibitor. | |||
T4367 | Mycro 3 | Mycro-3 | c-Myc , Autophagy |
Mycro 3 is potent and selective for c-Myc in whole cell assays. | |||
T6995 | Ochromycinone | STA 21,STA21,STA-21 | Antibacterial , STAT |
Ochromycinone (STA 21) is a selective STAT3 inhibitor. | |||
T21083 | TFIIH Modulator-19 | TFIIH Modulator19,TFIIH Modulator 19 | Others |
TFIIH Modulator-19 induces the dimerization of trichothiodystrophy group A protein to modulate TFIIH transcriptional activity. | |||
T6818 | DEL-22379 | DEL22379 | Apoptosis , ERK |
DEL-22379 is a water-soluble ERK dimerization inhibitor with IC50 of ~0.5 μM. | |||
T21082 | 2,5-Dihydroxybiphenyl | TFIIH Modulator 12,TFIIH Modulator12 | Others |
2,5-Dihydroxybiphenyl (TFIIH Modulator12), a small molecule destabilization inducer, induces the dimerization of trichothiodystrophy group A protein to modulate TFIIH transcriptional activity. | |||
T3686 | 10074-G5 | c-Myc , Autophagy | |
10074-G5 is an inhibitor of c-Myc-Max dimerization. | |||
T35074 | VRT-325 | CFcor 325,VRT-534,CFcor325,VRT 325,VRT325,CF-106951,CFcor-325 | Others |
VRT-325 can repair folding defects by promoting dimerization of the two NBDs or by promoting folding of the TMD.VRT-325 accelerates the healing rate of CF cell monolayers. | |||
T6908 | NSC 228155 | NSC228155 | EGFR , Epigenetic Reader Domain , DNA/RNA Synthesis , Histone Acetyltransferase |
NSC 228155 is an activator of EGFR, binding to the sEGFR dimerization domain II and modulate EGFR tyrosine phosphorylation. | |||
T7184 | Firsocostat | ND-630,NDI-010976,GS-0976 | Acetyl-CoA Carboxylase |
Firsocostat (GS-0976) is an inhibitor of acetyl-CoA carboxylase (ACC) dimerization that inhibits human ACC1 and ACC2 activity (IC50s of 2.1 and 6.1 nM, respectively) | |||
T60160 | STX-0119 | STAT | |
STX-0119 is a selective, orally active STAT3 dimerization inhibitor. STX-0119 inhibits STAT3 transcription with an IC50 of 74 μM. | |||
T9908 | Pembrolizumab | PD-1/PD-L1 | |
Pembrolizumab is a humanized monoclonal antibody inhibiting the PD-1 receptor and the first in the class of agents called the HER2 dimerization inhibitors that impairs the ability of HER2 to bind to other members of the ... | |||
T6308 | Stattic | STAT3 Inhibitor V | Apoptosis , STAT |
Stattic (STAT3 Inhibitor V) is a STAT3 inhibitor (IC50=5.1 μM) that selectively inhibits STAT3 activation, dimerization, and nuclear translocation. Stattic has antitumor activity and induces apoptosis. | |||
T9909 | Pertuzumab | EGFR | |
Pertuzumab (anti-HER2) a humanized monoclonal antibody and the first in the class of agents called the HER2 dimerization inhibitors impairs the ability of HER2 to bind to other members of the HER family. | |||
T14091 | AC-73 | Autophagy | |
AC-73 is an orally available Cluster of Differentiation 147 (CD147) inhibitor with high bioavailability that selectively disrupts the dimerization of CD147 (the binding site is in the N-terminal IgC2 domain of CD147 incl... | |||
T76776 | Emactuzumab | RO 5509554,RG 7155 | c-Fms , TAM Receptor |
Emactuzumab(RG 7155) is a monoclonal antibody against colony-stimulating factor-1 receptor targeting tumor-associated macrophages (TAMs) Emactuzumab has antitumor activity and inhibits activation of colony-stimulating fa... | |||
T38108 | Fulvic Acid | Antioxidant , PDE | |
Fulvic Acid is a natural product of humus produced by microorganisms in soil, sediment or aquatic environments. Fulvic acid is a phenolic acid and fungal metabolite isolated from Penicillium for the first time. Fulvic Ac... | |||
T10291 | α-Truxillic acid | Others | |
α-Truxillic acid, known for its anti-inflammatory activities, is produced through the dimerization of two molecules of α-trans-cinnamic acid. | |||
T35159 | XCT0135908 | XCT 0135908,XCT-0135908 | |
XCT0135908 is a selectivity agonist of RXR -Nurr1 over a broad range of other RXR dimerization partners but with a rather low potency. |